Affidea Group selects b-rayZ as its preferred AI partner in breast imaging, marking strategic collaboration

▤ Summary

Affidea selected b-rayZ as its preferred AI partner for breast imaging across its European diagnostic network. The companies are already using the solution in several countries and plan further expansion into additional Affidea markets. Affidea also joined b-rayZ as a strategic investor in a Series A extension, which strengthens the commercial and development relationship. The partnership aims to improve diagnostic accuracy, standardize workflows, and support earlier breast cancer detection.

▦ Linked Companies

B-Rayz

$1M to $5M